HYDROXYZINE HYDROCHLORIDE INJECTION USP 50 MG
HYDROXYZINE HYDROCHLORIDE : 50 MG · DIN 00742813 · SANDOZ CANADA INCORPORATED
Health Canada status: MARKETED
What is HYDROXYZINE HYDROCHLORIDE INJECTION USP?
HYDROXYZINE HYDROCHLORIDE INJECTION USP 50 MG contains HYDROXYZINE HYDROCHLORIDE : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 00742813, held by SANDOZ CANADA INCORPORATED, supplied as LIQUID for INTRAMUSCULAR administration. Health Canada currently lists it as marketed, status dated 21-Sep-2005. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is HYDROXYZINE HYDROCHLORIDE INJECTION USP used for?
HYRDOXYZINE HYDROCHLORIDE INJECTION USP (hydroxyzine hydrochloride) is indicated for: the symptomatic alleviation of pathological anxiety in patients with psychoneurotic disorders; the alleviation of acutely disturbed psychoneurotic patients; the alleviation of excessive anxiety and tension prior to surgical procedures; the reduction in narcotic dosage and controls emesis, when used as pre and postoperative medication; the symptomatic management of patients with acute alcoholic withdrawal.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 00742813 |
|---|---|
| Brand name | HYDROXYZINE HYDROCHLORIDE INJECTION USP |
| Generic / active ingredient | HYDROXYZINE HYDROCHLORIDE : 50 MG |
| Manufacturer | SANDOZ CANADA INCORPORATED |
| Strength | 50 MG |
| Dosage form | LIQUID |
| Route of administration | INTRAMUSCULAR |
| Schedule | Prescription |
| ATC code | N05BB01 HYDROXYZINE |
| AHFS class | 28:24.92 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 21-Sep-2005 |
| Original market date | 1987-12-31 00:00:00 |
How is it stored and handled?
Store between 15 and 30°C. Protect from light.
How is it supplied?
1 mL amber ampoules, boxes of 10
Is HYDROXYZINE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Resolved — reported by AA PHARMA INC, last seen 16 Jun 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
Check availability for HYDROXYZINE HYDROCHLORIDE INJECTION USP
What can be used instead?
Other Canadian products sharing ATC code N05BB01 HYDROXYZINE. 5 of 29 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ATARAX | 10 MG / 5 ML | SYRUP | SEARCHLIGHT PHARMA INC | MARKETED | DIN 00024694 |
| HYDROXYZINE | 10 MG | CAPSULE | AA PHARMA INC | MARKETED | DIN 00646059 |
| HYDROXYZINE | 25 MG | CAPSULE | AA PHARMA INC | MARKETED | DIN 00646024 |
| HYDROXYZINE | 50 MG | CAPSULE | AA PHARMA INC | MARKETED | DIN 00646016 |
| ATARAX CAP 10MG | 10 MG | CAPSULE | ERFA CANADA 2012 INC | CANCELLED POST MARKET | DIN 00024376 |
| ATARAX CAP 25MG | 25 MG | CAPSULE | ERFA CANADA 2012 INC | CANCELLED POST MARKET | DIN 00024384 |
| ATARAX CAP 50MG | 50 MG | CAPSULE | ERFA CANADA 2012 INC | CANCELLED POST MARKET | DIN 00024392 |
| ATARAX IM SOL 50MG/ML | 50 MG | SOLUTION | ERFA CANADA 2012 INC | CANCELLED POST MARKET | DIN 00024589 |
| HYDROXYZINE HYDROCHLORIDE INJECTION | 50 MG | LIQUID | FRESENIUS KABI CANADA LTD | CANCELLED PRE MARKET | DIN 02242864 |
| HYDROXYZINE HYDROCHLORIDE INJECTION, USP | 50 MG | SOLUTION | STERIMAX INC | DORMANT | DIN 02231209 |
Who else supplies HYDROXYZINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. HYDROXYZINE appears in 24 registered pack listings across 8 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.